Related Experiment Video
Updated: May 26, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Advances in the laboratory evaluation of peripheral neuropathies
Mengjing Chloe Huan1, Mark Bromberg
1Intermountain Health Care Neurosciences Center, 5171 South Cottonwood Street, #810, Murray, UT 84107, USA. chloe.huan@imail.org
Abstract:
Peripheral neuropathy is a common clinical problem in neurology and laboratory testing is an integral part of diagnosis. In the past few years, practice parameters have been published to establish an evidence-based guide to neuropathy testing. There are many tests that are common and accepted in practice, but there is no clear mandate on which tests are necessary. This article reviews recent practice parameter publications as well as other updates in laboratory testing for peripheral neuropathy, including the roles of lipid profile, genetic testing, antibody titers, and B(12) testing in a specific dopamine-treated Parkinson's patients. These can serve as recommendations to help guide laboratory testing.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Diabetic Neuropathy

